Screener
Gilead Sciences GILD Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Gilead Sciences’s reported figures.
Based on the most recent quarter.
The source filing: Gilead Sciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000882095-26-000024
FAQ
- What is Gilead Sciences's debt-to-equity?
- Gilead Sciences (GILD) reported debt-to-equity of 0.9× in Q1 2026.
- How has Gilead Sciences's debt-to-equity changed year-over-year?
- Gilead Sciences's debt-to-equity decreased by 27.6% year-over-year, from 1.3× to 0.9×.
- What is the long-term trend for Gilead Sciences's debt-to-equity?
- Over 5 years (2020 to 2025), Gilead Sciences's debt-to-equity has grown at a -8.6% compound annual growth rate (CAGR), from 1.8× to 1.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Gilead Sciences's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude